A GENE REQUIRED FOR CLASS-II-RESTRICTED ANTIGEN PRESENTATION MAPS TO THE MAJOR HISTOCOMPATIBILITY COMPLEX

被引:104
|
作者
MELLINS, E
KEMPIN, S
SMITH, L
MONJI, T
PIOUS, D
机构
[1] UNIV WASHINGTON,DEPT PEDIAT,SEATTLE,WA 98105
[2] UNIV WASHINGTON,DEPT MICROBIOL,SEATTLE,WA 98105
[3] UNIV WASHINGTON,DEPT IMMUNOL,SEATTLE,WA 98105
来源
JOURNAL OF EXPERIMENTAL MEDICINE | 1991年 / 174卷 / 06期
关键词
D O I
10.1084/jem.174.6.1607
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We have previously described a set of mutants (16.23-selected mutants) of a B lymphoblastoid cell line that are defective in the presentation of intact proteins to class II-restricted T cells, but effectively present immunogenic peptides. The mutations in these mutants are recessive in somatic cell hybrids and are not in Class II structural genes. Here, we report on a unique mutant, 5.2.4, in which a similar defect in class II-restricted antigen presentation has occurred in association with a one-megabase homozygous deletion in the class II region of the major histocompatibility complex (MHC). The defects in class II presentation among three of the 16.23-selected mutants, and between these mutants and 5.2.4, are noncomplementary in somatic cell hybrids. This suggests that the class II presentation-defective phenotype in all four mutants results from lesions in a single MHC-linked gene, a conclusion strengthened by the finding that in a hybrid made with a second, unrelated MHC deletion mutant, T2, the class II presentation defect in a 16.23-selected mutant is also not complemented. Mutant 5.2.4, in addition to its class II presentation defect, is also defective in surface expression of MHC class I molecules, most likely because its deletion encompasses the peptide supply factor 1 gene, whose function is known to be required for normal abundance of cell surface class I molecules. However, the surface abundance of class I molecules is normal in the 16.23-selected mutants, suggesting that.the lesions affecting class I surface abundance and class II presentation result from mutations in different genes.
引用
收藏
页码:1607 / 1615
页数:9
相关论文
共 50 条
  • [1] MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II-RESTRICTED ANTIGEN PRESENTATION ACROSS A SPECIES BARRIER - CONSERVATION OF RESTRICTION DETERMINANTS IN EVOLUTION
    BONTROP, RE
    ELFERINK, DG
    OTTING, N
    JONKER, M
    DEVRIES, RRP
    JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 172 (01): : 53 - 59
  • [2] PALMITIC ACID CONJUGATION OF A PROTEIN ANTIGEN ENHANCES MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II-RESTRICTED PRESENTATION TO T-CELLS
    ROBINSON, JH
    CASE, MC
    BROOKS, CG
    IMMUNOLOGY, 1992, 76 (04) : 593 - 598
  • [3] Major histocompatibility complex class II-restricted presentation of a cytosolic antigen by autophagy
    Nimmerjahn, F
    Milosevic, S
    Behrends, U
    Jaffee, EM
    Pardoll, DM
    Bornkamm, GW
    Mautner, J
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2003, 33 (05) : 1250 - 1259
  • [4] MHC CLASS-II-RESTRICTED PRESENTATION OF INTRACELLULAR ANTIGEN
    WEISS, S
    BOGEN, B
    CELL, 1991, 64 (04) : 767 - 776
  • [5] Major histocompatibility complex class I-restricted antigen processing and presentation
    Van Kaer, L
    TISSUE ANTIGENS, 2002, 60 (01): : 1 - 9
  • [6] MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II-RESTRICTED PRESENTATION OF AN INTERNALLY SYNTHESIZED ANTIGEN DISPLAYS CELL-TYPE VARIABILITY AND SEGREGATES FROM THE EXOGENOUS CLASS-II AND ENDOGENOUS CLASS-I PRESENTATION PATHWAYS
    LOSS, GE
    ELIAS, CG
    FIELDS, PE
    RIBAUDO, RK
    MCKISIC, M
    SANT, AJ
    JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (01): : 73 - 85
  • [7] Mechanisms of major histocompatibility complex class II-restricted processing and presentation of the V antigen of Yersinia pestis
    Shim, Ho-Ki
    Musson, Julie A.
    Harper, Helen M.
    McNeill, Hesta V.
    Walker, Nicola
    Flick-Smith, Helen
    von Delwig, Alexei
    Williamson, E. Diane
    Robinson, John H.
    IMMUNOLOGY, 2006, 119 (03) : 385 - 392
  • [8] DELIVERY OF PROTEIN ANTIGEN TO THE MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I-RESTRICTED ANTIGEN PRESENTATION PATHWAY
    ZHOU, F
    HUANG, L
    JOURNAL OF DRUG TARGETING, 1995, 3 (02) : 91 - 109
  • [9] Major histocompatibility complex class II antigen presentation in Hodgkin's disease
    Bosshart, H
    LEUKEMIA & LYMPHOMA, 1999, 36 (1-2) : 9 - +
  • [10] The role of H2-0 in major histocompatibility complex class II-restricted antigen processing and presentation
    Alfonso, C
    Karlsson, L
    FASEB JOURNAL, 2000, 14 (06): : A1159 - A1159